Stock ORCHPHARMA ORCHID PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Orchid Pharma Limited

Equities

ORCHPHARMA

INE191A01027

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 03:10:33 2024-05-17 am EDT 		5-day change 1st Jan Change
1,088 INR +0.69% Intraday chart for Orchid Pharma Limited +5.16% +52.70%
Apr. 12 Orchid Pharma Limited Announces Resignation of Mudit Tandon as Independent Director CI
Feb. 23 Orchid Pharma Receives United States Food and Drug Administration Approval for Its Novel Invention CI

Business Summary

Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of integrated active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

Number of employees: 838

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceuticals
100.0 %
5,596 100.0 % 6,659 100.0 % +19.00%

Sales per region

INR in Million2022Weight2023Weight Delta
Rest of the World
82.9 %
4,795 85.7 % 5,517 82.9 % +15.07%
India
15.6 %
766 13.7 % 1,039 15.6 % +35.60%
Global
1.5 %
35 0.6 % 103 1.5 % +195.23%

Managers

Managers TitleAgeSince
Manish Dhanuka CEO
 Chief Executive Officer 56 20-03-30
Sunil Kumar Gupta DFI
 Director of Finance/CFO - 20-06-28
Kapil Dayya CMP
 Compliance Officer - Dec. 15
Chellapandi D. CTO
 Chief Tech/Sci/R&D Officer - -
Pragati Kumar Patro CTO
 Chief Tech/Sci/R&D Officer - 07-02-14
S. Mani PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Ram Gopal Agarwal CHM
 Chairman 74 20-03-30
Mridul Dhanuka BRD
 Director/Board Member 42 20-03-30
Manish Dhanuka CEO
 Chief Executive Officer 56 20-03-30
Tanu Singla BRD
 Director/Board Member 38 20-06-28
Dharam Vir BRD
 Director/Board Member 43 20-06-28
Manoj Goyal BRD
 Director/Board Member 47 20-06-28
Arjun Dhanuka BRD
 Director/Board Member - 23-10-19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 50,719,100 13,202,662 ( 26.03 %) 0 26.03 %

Shareholders

NameEquities%Valuation
Dhanuka Laboratories Ltd.
69.84 %
35,419,957 69.84 % 457 M ₹
quant Money Managers Ltd.
6.834 %
3,465,947 6.834 % 45 M ₹
Invesco Asset Management (India) Pvt Ltd.
3.975 %
2,015,991 3.975 % 26 M ₹
Massachusetts Institute of Technology
3.590 %
1,821,000 3.590 % 24 M ₹
Nippon Life India Asset Management Ltd. (Invt Mgmt)
1.426 %
723,032 1.426 % 9 M ₹
Carnelian Asset Management & Advisors Pvt Ltd.
1.220 %
618,919 1.220 % 8 M ₹
Tata Asset Management Ltd.
0.8517 %
431,964 0.8517 % 6 M ₹
JM Financial Asset Management Ltd.
0.8361 %
424,079 0.8361 % 5 M ₹
UTI Asset Management Co. Ltd. (Investment Management)
0.8119 %
411,804 0.8119 % 5 M ₹
Bajaj Finserv Asset Management Ltd.
0.5193 %
263,375 0.5193 % 3 M ₹

Company contact information

Orchid Pharma Ltd.

SIDCO Industrial Estate Alathur Chengalpattu District

603110, Chennai

+91 44 2821 1000

http://www.orchidpharma.com
address Orchid Pharma Limited(ORCHPHARMA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1,080 INR
Average target price
1,130 INR
Spread / Average Target
+4.58%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ORCHID PHARMA LIMITED Stock Orchid Pharma Limited
+52.70% 656M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+32.36% 694B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.81% 593B
JOHNSON & JOHNSON Stock Johnson & Johnson
-1.60% 371B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.07% 331B
ABBVIE INC. Stock AbbVie Inc.
+6.04% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.62% 239B
NOVARTIS AG Stock Novartis AG
+10.12% 209B
ROCHE HOLDING AG Stock Roche Holding AG
-3.23% 209B
AMGEN INC. Stock Amgen Inc.
+9.27% 169B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ORCHPHARMA Stock
  4. Company Orchid Pharma Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW